NZ767226A - Egg protein formulations and methods of manufacture thereof - Google Patents
Egg protein formulations and methods of manufacture thereofInfo
- Publication number
- NZ767226A NZ767226A NZ767226A NZ76722615A NZ767226A NZ 767226 A NZ767226 A NZ 767226A NZ 767226 A NZ767226 A NZ 767226A NZ 76722615 A NZ76722615 A NZ 76722615A NZ 767226 A NZ767226 A NZ 767226A
- Authority
- NZ
- New Zealand
- Prior art keywords
- egg
- protein formulations
- egg protein
- methods
- formulations
- Prior art date
Links
- 102000002322 Egg Proteins Human genes 0.000 title abstract 7
- 108010000912 Egg Proteins Proteins 0.000 title abstract 7
- 238000009472 formulation Methods 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 7
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 208000004739 Egg Hypersensitivity Diseases 0.000 abstract 2
- 206010016946 Food allergy Diseases 0.000 abstract 1
- 201000010860 egg allergy Diseases 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies. Provided herein are egg protein formulations for use in the treatment of egg allergy. Also provided herein is a method for identifying and manufacturing egg protein formulations.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462041362P | 2014-08-25 | 2014-08-25 | |
| NZ72908215 | 2015-08-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ767226A true NZ767226A (en) | 2023-07-28 |
Family
ID=87654784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ767226A NZ767226A (en) | 2014-08-25 | 2015-08-25 | Egg protein formulations and methods of manufacture thereof |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ767226A (en) |
-
2015
- 2015-08-25 NZ NZ767226A patent/NZ767226A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4275760A3 (en) | Egg protein formulations and methods of manufacture thereof | |
| MX2019008419A (en) | Methods of manufacture of nut flours and formulations for oral immunotherapy. | |
| JOP20200192A1 (en) | Anti-tigit antibodies | |
| MX2021007268A (en) | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino}acetic acid, compositions, and uses thereof. | |
| WO2014176128A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
| EA201500314A1 (en) | DOSAGE FORMS OF ENZALUTAMIDE | |
| MX2021008755A (en) | Methods of treating a tauopathy. | |
| PH12017500032A1 (en) | Improved a� protofibril binding antibodies | |
| EA201492040A1 (en) | BICYCLICALLY SUBSTITUTED URACILES AND THEIR APPLICATION | |
| CA166702S (en) | Blood pressure monitor | |
| CA166574S (en) | Blood pressure monitor | |
| TW201613636A (en) | Methods of treating Alzheimer's Disease | |
| EP3052641A4 (en) | Hydrolysate of animal protein, manufacturing method thereof and use thereof | |
| EA201692284A1 (en) | NIACINAMIDE FOR STIMULATING THE PRODUCTION OF ANTIMICROBIAL PEPTIDES | |
| EP3565607A4 (en) | Fusogenic lipid nanoparticles and methods for manufacturing and use for therapeutic protein production and for treatment | |
| EA201890442A1 (en) | OBTAINING PHOTORECEPTORS FOR THE TREATMENT OF RETITAL DISEASES | |
| BR112016019389A2 (en) | vaccine and peptide | |
| SG10201805646WA (en) | Angiopoietin-like 4 antibodies and methods of use | |
| MX2013010367A (en) | Compositions and methods for the therapy and diagnosis of influenza. | |
| MX2017001433A (en) | Microscale bioprocessing system and method for protein manufacturing from human blood. | |
| EA201500765A1 (en) | METHODS OF TREATING CARDIOVASCULAR DISEASES | |
| PH12017501979A1 (en) | Pharmaceutical compound | |
| NZ767226A (en) | Egg protein formulations and methods of manufacture thereof | |
| PL419074A1 (en) | Medical application of magnoflorine | |
| UA109727C2 (en) | Method for treatment of hair loss |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: SOCIETE DES PRODUITS NESTLE S.A., CH Effective date: 20220215 |
|
| PSEA | Patent sealed |